CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

Clinical trial NCT02827890 · COMPLETED

Trial details

NCT number: NCT02827890
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2016-04-01
Primary completion: 2016-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.